Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Christian Lienhardt et al.|Clinical Infectious Diseases|2016Cited by 1.5k
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 321
Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and TuberculosisMarc Weiner, Thomas Hodge, Debra Benator et al.|Clinical Infectious Diseases|2005Cited by 227
Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine ModelIan M. Rosenthal, Eric L. Nuermberger, Ming Zhang et al.|PLoS Medicine|2007Cited by 212
Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and RifapentineMarc Weiner, Thomas Hodge, William J. Burman et al.|American Journal of Respiratory and Critical Care Medicine|2003Cited by 193